[go: up one dir, main page]

CY1109458T1 - Ιστικο μοσχευμα - Google Patents

Ιστικο μοσχευμα

Info

Publication number
CY1109458T1
CY1109458T1 CY20091101027T CY091101027T CY1109458T1 CY 1109458 T1 CY1109458 T1 CY 1109458T1 CY 20091101027 T CY20091101027 T CY 20091101027T CY 091101027 T CY091101027 T CY 091101027T CY 1109458 T1 CY1109458 T1 CY 1109458T1
Authority
CY
Cyprus
Prior art keywords
hygiene
injury
relates
vascular
graft material
Prior art date
Application number
CY20091101027T
Other languages
English (en)
Inventor
Jeremy D Ollerenshaw
Steven Goldstein
Kirby S Black
Original Assignee
Cryolife, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cryolife, Inc. filed Critical Cryolife, Inc.
Publication of CY1109458T1 publication Critical patent/CY1109458T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Graft Or Block Polymers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μια μέθοδο παρασκευής ενός υλικού ιστικού μοσχεύματος. Η εφεύρεση αναφέρεται επίσης σε ένα υλικό ιστικού μοσχεύματος πολλαπλού σκοπού και σε μεθόδους χρησιμοποίησης αυτού ως ένα υποκατάστατο για αγγειακό και μη αγγειακό ιστό.
CY20091101027T 2000-01-28 2009-10-02 Ιστικο μοσχευμα CY1109458T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17863200P 2000-01-28 2000-01-28
US09/769,769 US6866686B2 (en) 2000-01-28 2001-01-26 Tissue graft
EP05076303A EP1591078B1 (en) 2000-01-28 2001-01-29 Tissue graft

Publications (1)

Publication Number Publication Date
CY1109458T1 true CY1109458T1 (el) 2014-08-13

Family

ID=26874499

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101027T CY1109458T1 (el) 2000-01-28 2009-10-02 Ιστικο μοσχευμα

Country Status (12)

Country Link
US (3) US6866686B2 (el)
EP (2) EP1250109A4 (el)
JP (1) JP5142437B2 (el)
AU (1) AU783780B2 (el)
CA (1) CA2396698C (el)
CY (1) CY1109458T1 (el)
DE (1) DE60139279D1 (el)
DK (1) DK1591078T3 (el)
ES (1) ES2329480T3 (el)
NO (1) NO327637B1 (el)
PT (1) PT1591078E (el)
WO (1) WO2001054619A1 (el)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2263185T3 (es) * 1996-12-10 2006-12-01 Purdue Research Foundation Biomaterial derivado de tejido hepatico de vertebrados.
US6866686B2 (en) * 2000-01-28 2005-03-15 Cryolife, Inc. Tissue graft
AU2001284968B2 (en) * 2000-08-16 2006-12-21 Duke University Decellularized tissue engineered constructs and tissues
US20030185702A1 (en) * 2002-02-01 2003-10-02 Wilson Burgess Methods for sterilizing tissue
US20110091353A1 (en) * 2001-09-24 2011-04-21 Wilson Burgess Methods for Sterilizing Tissue
US20030124023A1 (en) * 2001-12-21 2003-07-03 Wilson Burgess Method of sterilizing heart valves
US7919121B2 (en) * 2002-01-11 2011-04-05 Purdue Research Foundation Biomaterial derived from vertebrate liver tissue
US20030180181A1 (en) * 2002-02-01 2003-09-25 Teri Greib Methods for sterilizing tissue
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
EP1649879A3 (en) * 2002-06-28 2006-05-03 Cardio, Inc. Decellularized tissue
US20040187877A1 (en) * 2002-12-04 2004-09-30 Badylak Stephen F. Method for repair of liver tissue
US20040191226A1 (en) * 2002-12-04 2004-09-30 Badylak Stephen F. Method for repair of body wall
US20040161362A1 (en) * 2002-12-27 2004-08-19 Bogert David L. Audible range acoustic cleaning process for implants
JPWO2005063314A1 (ja) * 2003-12-26 2007-12-20 株式会社カルディオ 脱細胞化組織およびその作成方法
US9216236B2 (en) 2005-03-07 2015-12-22 Technion Research & Development Foundation Limited Natural tissue-derived decellularized matrix and methods of generating and using same
BRPI0612121A2 (pt) * 2005-06-30 2016-09-06 Anthrogenesis Corp método de reparo de uma membrana timpânica que tenha uma deformidade, e, biotecido de colágeno
US7658706B2 (en) * 2005-12-05 2010-02-09 Rti Biologics, Inc. Vascular graft sterilization and decellularization
GB0606231D0 (en) 2006-03-29 2006-05-10 Univ Leeds Improvements relating to decellurisation of tissue matrices for bladder implantation
WO2007124127A2 (en) * 2006-04-21 2007-11-01 Wake Forest University Health Sciences Structurally modified acellular tissue engineering scaffolds and methods of production
WO2007146123A2 (en) * 2006-06-09 2007-12-21 Anthrogenesis Corporation Placental niche and use thereof to culture stem cells
WO2008021391A1 (en) * 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
WO2008042441A1 (en) * 2006-10-03 2008-04-10 Anthrogenesis Corporation Use of umbilical cord biomaterial for ocular surgery
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
ES2516698T3 (es) * 2006-10-06 2014-10-31 Anthrogenesis Corporation Composiciones de colágeno placentario (telopéptido) nativo
EP2113261B1 (en) 2008-04-29 2013-11-06 Proxy Biomedical Limited A Tissue Repair Implant
CN102271634B (zh) 2008-11-04 2015-01-14 斯特拉塔特克公司 即用型经干燥和经辐照的皮肤等同物
EP2352529B1 (en) * 2008-11-04 2018-07-11 inRegen Cell-scaffold constructs
US9150318B1 (en) 2009-01-02 2015-10-06 Lifecell Corporation Method for sterilizing an acellular tissue matrix
US8628572B2 (en) 2009-02-26 2014-01-14 Wake Forest University Health Sciences Corneal endothelial scaffolds and methods of use
WO2010101883A2 (en) * 2009-03-06 2010-09-10 Mayo Foundation For Medical Education And Research Tendon or ligament tissue engineering
EP2405742A2 (en) * 2009-03-11 2012-01-18 CryoLife, Inc. Bioburden-reducing antibiotic composition and method of use
US8906362B2 (en) 2009-03-23 2014-12-09 Wake Forest University Health Sciences Tissue engineered meniscus scaffolds and methods of use
WO2011068778A1 (en) * 2009-12-03 2011-06-09 Lifecell Corporation Nerve treatment devices and methods
ES2719816T3 (es) 2010-02-26 2019-07-16 Decell Tech Inc Métodos para la descelularización de tejidos
JP2013165740A (ja) * 2010-05-14 2013-08-29 Waseda Univ 無細胞化方法及び人体移植用人工組織
US8475827B2 (en) 2010-07-06 2013-07-02 Cryolife, Inc. Tissue implants for implantation and methods for preparing the same
US8377143B2 (en) 2010-07-06 2013-02-19 Cryolife, Inc. Tissue implants for implantation and methods for preparing the same
WO2012031233A2 (en) * 2010-09-03 2012-03-08 The General Hospital Corporation Blood vessel grafts for repair, reconstruction and filler materials
US9089523B2 (en) 2011-07-28 2015-07-28 Lifecell Corporation Natural tissue scaffolds as tissue fillers
CA3018082C (en) * 2011-10-14 2021-06-29 Humacyte, Inc. Tubular prostheses
WO2013147299A1 (ja) * 2012-03-31 2013-10-03 学校法人早稲田大学 生体組織の処理方法及び生体組織
EP3777906A1 (en) * 2012-07-06 2021-02-17 LifeCell Corporation Decellularized muscle matrix
EP2892541B1 (en) 2012-09-04 2021-04-21 Technion Research & Development Foundation Limited Use of decellularized extracellular matrix for encapsulating cells
CA2919374C (en) 2013-07-30 2019-12-03 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
WO2015066668A1 (en) 2013-11-04 2015-05-07 Lifecell Corporation Methods of removing alpha-galactose
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
US10945831B2 (en) 2016-06-03 2021-03-16 Musculoskeletal Transplant Foundation Asymmetric tissue graft
USD856517S1 (en) 2016-06-03 2019-08-13 Musculoskeletal Transplant Foundation Asymmetric tissue graft
US10639398B2 (en) 2016-07-05 2020-05-05 Lifecell Corporation Tissue matrices incorporating multiple tissue types
JP2018033694A (ja) * 2016-08-31 2018-03-08 新幹工業株式会社 結合組織体の形成方法
EP3306347B1 (en) * 2016-10-10 2022-07-06 Trimble Inc. System and method for registration of survey points
CN107890586B (zh) * 2017-10-27 2021-06-01 百澳瑞派（天津）生物科技有限公司 一种同种异体生物乳房补片的制备方法
US10813743B2 (en) 2018-09-07 2020-10-27 Musculoskeletal Transplant Foundation Soft tissue repair grafts and processes for preparing and using same
USD895812S1 (en) 2018-09-07 2020-09-08 Musculoskeletal Transplant Foundation Soft tissue repair graft
US20200129309A1 (en) * 2018-10-30 2020-04-30 Surgentec, Llc Method and container for delivering bone graft material

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1358465A (fr) * 1963-02-21 1964-04-17 Procédé de traitement de tissus animaux, en particulier en vue de la séparation de polysaccharides
US3551560A (en) * 1967-10-02 1970-12-29 Heinrich F Thiele Process of reconstructing tendons,cartilage,nerve sheaths,and products
US3927422A (en) 1973-12-12 1975-12-23 Philip Nicholas Sawyer Prosthesis and method for making same
US4082507A (en) 1976-05-10 1978-04-04 Sawyer Philip Nicholas Prosthesis and method for making the same
WO1982000091A1 (en) 1980-07-01 1982-01-21 V Ketharanathan Vascular prostheses
JPS58180162A (ja) 1982-04-19 1983-10-21 株式会社高研 抗血栓性医用材料
US4695281A (en) 1983-03-25 1987-09-22 Koken Co., Ltd. Medical material
US4801299A (en) 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US4759757A (en) 1984-04-18 1988-07-26 Corvita Corporation Cardiovascular graft and method of forming same
US4657544A (en) 1984-04-18 1987-04-14 Cordis Corporation Cardiovascular graft and method of forming same
US4755593A (en) 1985-07-24 1988-07-05 Lauren Mark D Novel biomaterial of cross-linked peritoneal tissue
GB8618374D0 (en) 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
ATE109491T1 (de) * 1988-03-11 1994-08-15 Chemokol G B R Ing Buero Fuer Verfahren zur herstellung von kollagenmembranen für hämostase, wundbehandlung und implantate.
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US5080198A (en) * 1990-02-06 1992-01-14 Rice Gene A Apparatus for greasing wheel bearings
US5209776A (en) * 1990-07-27 1993-05-11 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5336616A (en) 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
US5632776A (en) * 1990-11-22 1997-05-27 Toray Industries, Inc. Implantation materials
US5690675A (en) * 1991-02-13 1997-11-25 Fusion Medical Technologies, Inc. Methods for sealing of staples and other fasteners in tissue
CA2101557A1 (en) 1991-02-14 1992-08-15 Roger Tu Pliable biological graft materials and their methods of manufacture
US5192312A (en) 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
EP0566245B1 (en) 1992-03-19 1999-10-06 Medtronic, Inc. Intraluminal stent
US5523291A (en) * 1993-09-07 1996-06-04 Datascope Investment Corp. Injectable compositions for soft tissue augmentation
US5460962A (en) * 1994-01-04 1995-10-24 Organogenesis Inc. Peracetic acid sterilization of collagen or collagenous tissue
DK0871414T3 (da) 1994-03-14 2004-08-30 Cryolife Inc Fremgangsmåder til fremstilling af væv til implantering
US5595571A (en) 1994-04-18 1997-01-21 Hancock Jaffe Laboratories Biological material pre-fixation treatment
JPH09512463A (ja) * 1994-04-29 1997-12-16 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 天然内皮下基質を利用した改善された血液接触表面並びにその製造及び利用方法
US5716394A (en) * 1994-04-29 1998-02-10 W. L. Gore & Associates, Inc. Blood contact surfaces using extracellular matrix synthesized in vitro
FR2728898B1 (fr) * 1994-12-29 1997-01-31 Rhone Poulenc Chimie Procede de preparation d'acides carboxyliques par oxydation menagee des alcanes correspondants
US6039755A (en) 1997-02-05 2000-03-21 Impra, Inc., A Division Of C.R. Bard, Inc. Radially expandable tubular polytetrafluoroethylene grafts and method of making same
JPH11508151A (ja) * 1995-04-07 1999-07-21 パーデュー・リサーチ・ファウンデーション 膀胱再建方法及び膀胱再建用組織グラフト
EP0821573A4 (en) 1995-04-19 2000-08-09 St Jude Medical SUBSTRATE MATRICE FOR A PROSTHESIS CONSISTING OF BIOLOGICAL LIVING TISSUE AND METHOD FOR PRODUCING THIS MATRICE
US5657544A (en) * 1995-09-26 1997-08-19 Ntn Corporation Device for detecting the angle of rotation
JPH09122227A (ja) 1995-10-31 1997-05-13 Bio Eng Lab:Kk 医用材料およびその製造方法
US5607478A (en) 1996-03-14 1997-03-04 Meadox Medicals Inc. Yarn wrapped PTFE tubular prosthesis
US5755791A (en) * 1996-04-05 1998-05-26 Purdue Research Foundation Perforated submucosal tissue graft constructs
US6010529A (en) 1996-12-03 2000-01-04 Atrium Medical Corporation Expandable shielded vessel support
EP1671604B1 (en) * 1996-12-10 2009-07-22 Purdue Research Foundation Synthetic tissue valve
EP1018983A4 (en) 1997-02-07 2006-09-27 Providence Health Sys Oregon PROCESS FOR PRODUCING BIOMATERIALS
US6048360A (en) 1997-03-18 2000-04-11 Endotex Interventional Systems, Inc. Methods of making and using coiled sheet graft for single and bifurcated lumens
EP0987998B1 (en) 1997-04-11 2004-10-13 CryoLife, Inc. Tissue decellularization
US6206917B1 (en) 1997-05-02 2001-03-27 St. Jude Medical, Inc. Differential treatment of prosthetic devices
US5993844A (en) 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
US6371992B1 (en) * 1997-12-19 2002-04-16 The Regents Of The University Of California Acellular matrix grafts: preparation and use
WO1999066965A1 (de) * 1998-06-25 1999-12-29 Vascular Biotech Gmbh Autologe epithelialisierung bzw. endothelialisierung von hohlorganen bzw. gefässen
US20100030340A1 (en) * 1998-06-30 2010-02-04 Wolfinbarger Jr Lloyd Plasticized Grafts and Methods of Making and Using Same
US6866686B2 (en) 2000-01-28 2005-03-15 Cryolife, Inc. Tissue graft
AUPR217300A0 (en) 2000-12-20 2001-01-25 Ketharanathan, Vettivetpillai Method of creating biological and biosynthetic material for implantation

Also Published As

Publication number Publication date
EP1250109A1 (en) 2002-10-23
ES2329480T3 (es) 2009-11-26
EP1591078A1 (en) 2005-11-02
PT1591078E (pt) 2009-10-21
EP1591078B1 (en) 2009-07-15
DE60139279D1 (de) 2009-08-27
NO327637B1 (no) 2009-09-07
US20100285587A1 (en) 2010-11-11
WO2001054619A1 (en) 2001-08-02
NO20023154D0 (no) 2002-06-28
US20050191281A1 (en) 2005-09-01
US6866686B2 (en) 2005-03-15
US7763081B2 (en) 2010-07-27
US20020128724A1 (en) 2002-09-12
AU783780B2 (en) 2005-12-08
NO20023154L (no) 2002-06-28
EP1250109A4 (en) 2003-04-02
DK1591078T3 (da) 2009-11-16
JP5142437B2 (ja) 2013-02-13
CA2396698A1 (en) 2001-08-02
AU3307201A (en) 2001-08-07
CA2396698C (en) 2010-11-02
JP2004500188A (ja) 2004-01-08

Similar Documents

Publication Publication Date Title
CY1109458T1 (el) Ιστικο μοσχευμα
CY1107087T1 (el) Μιμητικα θρομβοποιητινης
CY1106992T1 (el) Καχαλαλιδη f και συναφεις ενωσεις
PE20020521A1 (es) Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas
DK0987998T3 (da) Decellulering af væv
ATE420947T1 (de) Gewebeimplant zur wiederherstellung von knorpelgewebe
ATE376026T1 (de) Klebstoffzusammensetzungen mit selbstorganisierenden molekülen, klebstoffe, gegenstände und verfahren
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
DE60115874D1 (de) Instrument zur chirurgischen behandlung
ATE441706T1 (de) Konjugate mit biologisch abbaubarem polymer und verwendung dafür
ATE466072T1 (de) Bandscheibe
SG158153A1 (en) Compositions and methods for promoting wound healing and tissue regeneration
ATE296116T1 (de) Ein kovalentes konjugat von clozapine und einer fettsäure und dessen verwendung zur behandlung von schizophrenie
CY1106467T1 (el) Ελεγχομενη συνθεση ζιπρασιδονης
ATE552849T1 (de) Behandlungsverfahren unter verwendung von ctla-4 antikörpern
CY1112055T1 (el) Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα
DE60232263D1 (de) Ineinandergreifender endoluminaler Stent-Gewebe
DE60143706D1 (de) Absorbens und verfahren zu dessen herstellung, absorbierbare artikel und syntheseprodukte
BR0114059A (pt) Derivados de resorcinol
DE60136742D1 (de) Schaumbehandlung von tissueprodukten
ATE360442T1 (de) Verfahren und zusammensetzungen zur behandlung von hyperproliferativen zuständen
ATE263006T1 (de) Zweiteiliges schneidmesser zur herstellung von spiralgemüsebändern
ATE415163T1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων